new data from ionis htt rx phase 1 2 study demonstrates correlation between reduction of disease causing protein and improvement in clinical measures of huntingtons disease
New Data from IONIS-HTT Rx Phase 1/2 Study Demonstrates Correlation Between Reduction of Disease-causing Protein and Improvement in Clinical Measures of Huntington’s Disease